title: Endocrine and reproductive responses of male and female cattle to agonists of gonadotrophin-releasing hormone.
abstract: The pituitary response in cattle to treatment with GnRH agonist has two phases. In the acute phase secretion of LH is increased, while the chronic phase is characterized by a downregulation of GnRH receptors and insensitivity of gonadotrophs to natural sequence GnRH. After long-term treatment with GnRH agonist, cattle do not have pulsatile secretion of LH but maintain basal LH. This is associated with reduced pituitary contents of LH, LH mRNA, FSH and FSH mRNA. Long-term treatment of bulls with GnRH agonist results in an increase in testicular LH receptors and high plasma testosterone. Heifers treated with a GnRH agonist from early in the oestrous cycle develop a larger corpus luteum and secrete more progesterone. Increased steroidogenesis is reflected in increased steroid acute regulatory (StAR) protein and steroidogenic enzymes in the testes and corpus luteum. GnRH agonists have potential as novel strategies for reproductive management in cattle. A GnRH agonist bioimplant was recently used to block the LH surge after FSH stimulation of follicle growth in heifers. Ovulation was induced by injection of LH, and heifers were inseminated relative to the LH injection. This GnRH agonist-LH protocol provides a model for studying the gonadotrophin requirements for follicular growth and oocyte maturation in cattle, and will enable controlled in vivo maturation of oocytes before recovery for in vitro procedures.
authors.affiliation: Centre for Primary Industries Research, Central Queensland University, Rockhampton, Australia.
authors.forename: M J
authors.initials: MJ
authors.lastname: D'Occhio
authors.forename: W J
authors.initials: WJ
authors.lastname: Aspden
mesh_terms: D000818:Animals; D002417:Cattle / Q000502:physiology*; D004973:Estrus Synchronization; D005260:Female; D005298:Fertility / Q000187:drug effects; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists* / Q000494:pharmacology; D006062:Gonadotropins / Q000378:metabolism*; D008297:Male; D010053:Ovary / Q000187:drug effects; D010062:Ovulation Induction; D010903:Pituitary Gland, Anterior / Q000187:drug effects*; D011967:Receptors, Gonadotropin / Q000187:drug effects*; D013737:Testis / Q000187:drug effects
chemical_list: D006062:Gonadotropins; D011967:Receptors, Gonadotropin; D007987:Gonadotropin-Releasing Hormone